LEADER 01422nam  2200361Ia 450 
001 9910698822003321
005 20090529122917.0
035   $a(CKB)5470000002397649
035   $a(OCoLC)361875666
035   $a(EXLCZ)995470000002397649
100   $a20090529d2001      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for FDA reviewers$b[electronic resource] $epremarket notification submissions for empty containers for the collection and processing of blood and blood components
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,$d[2001]
215   $ai, 5 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on May 29, 2009).
300   $a"July 2001".
517   $aGuidance for FDA reviewers 
606   $aContainers$xGovernment policy$zUnited States
606   $aBlood$xCollection and preservation$xGovernment policy$zUnited States
615  0$aContainers$xGovernment policy
615  0$aBlood$xCollection and preservation$xGovernment policy
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698822003321
996   $aGuidance for FDA reviewers$93467137
997   $aUNINA